Trials / Conditions / Hospital Acquired Bacterial Pneumonia (HABP)
Hospital Acquired Bacterial Pneumonia (HABP)
5 registered clinical trials studyying Hospital Acquired Bacterial Pneumonia (HABP) — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus C NCT07431307 | BioVersys AG | Phase 2 |
| Not Yet Recruiting | Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in NCT07326540 | BioVersys SAS | Phase 3 |
| Recruiting | Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriace NCT07089186 | Qilu Pharmaceutical Co., Ltd. | Phase 3 |
| Recruiting | A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia NCT06841731 | Jiangsu HengRui Medicine Co., Ltd. | Phase 2 |
| Completed | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Part NCT04215991 | Shionogi | Phase 2 |